These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34035482)
1. LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1. Bai Y; Ren C; Wang B; Xue J; Li F; Liu J; Yang L Cancer Gene Ther; 2022 Mar; 29(3-4):277-291. PubMed ID: 34035482 [TBL] [Abstract][Full Text] [Related]
2. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15. Jia YC; Wang JY; Liu YY; Li B; Guo H; Zang AM Cell Biol Int; 2019 Apr; 43(4):384-393. PubMed ID: 30599080 [TBL] [Abstract][Full Text] [Related]
4. LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15. Li H; Zhang GY; Pan CH; Zhang XY; Su XY Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2838-2846. PubMed ID: 31002134 [TBL] [Abstract][Full Text] [Related]
5. Transcription factor ETV1-induced lncRNA MAFG-AS1 promotes migration, invasion, and epithelial-mesenchymal transition of pancreatic cancer cells by recruiting IGF2BP2 to stabilize ETV1 expression. Weng H; Feng W; Li F; Huang D; Lin L; Wang Z Growth Factors; 2023 Aug; 41(3):152-164. PubMed ID: 37428861 [TBL] [Abstract][Full Text] [Related]
6. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis. Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264 [TBL] [Abstract][Full Text] [Related]
7. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells. Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245 [TBL] [Abstract][Full Text] [Related]
8. Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha ( Zhou Y; Li J; Yang X; Song Y; Li H Bioengineered; 2021 Dec; 12(2):12003-12022. PubMed ID: 34787052 [TBL] [Abstract][Full Text] [Related]
9. LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer via restoration of BCL2L11 as a sponge of microRNA-340-5p. Chen J; Lin Y; Jia Y; Xu T; Wu F; Jin Y J Cell Physiol; 2019 Dec; 234(12):23421-23436. PubMed ID: 31222748 [TBL] [Abstract][Full Text] [Related]
10. LncRNA MAFG-AS1 is involved in human cancer progression. Li P; Ma X; Gu X Eur J Med Res; 2023 Nov; 28(1):497. PubMed ID: 37941063 [TBL] [Abstract][Full Text] [Related]
11. Carcinogenic roles of MAFG-AS1 in human cancers. Ahmadi M; Morshedzadeh F; Ghaderian SMH; Mousavi P; Habibipour L; Peymani M; Abbaszadegan MR; Ghafouri-Fard S Clin Transl Oncol; 2024 Jan; 26(1):52-68. PubMed ID: 37351806 [TBL] [Abstract][Full Text] [Related]
12. LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis. Sui Y; Lin G; Zheng Y; Huang W Eur J Pharmacol; 2019 Sep; 859():172465. PubMed ID: 31211984 [TBL] [Abstract][Full Text] [Related]
13. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis. Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis. Sun Z; Gao S; Xuan L; Liu X J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030 [TBL] [Abstract][Full Text] [Related]
15. LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4. Cui S; Yang X; Zhang L; Zhao Y; Yan W Biochem Biophys Res Commun; 2018 Nov; 506(1):251-258. PubMed ID: 30348529 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis. Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278 [TBL] [Abstract][Full Text] [Related]
17. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer. Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903 [TBL] [Abstract][Full Text] [Related]
18. HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA. Zhang F; Li Y; Gan L; Tong X; Qi D; Wang Q; Ye X FASEB J; 2021 May; 35(5):e21529. PubMed ID: 33813778 [TBL] [Abstract][Full Text] [Related]
19. LncRNA MAFG-AS1 Upregulates Polo-Like Kinase-1 by Sponging miR-505 to Promote Gastric Adenocarcinoma Cell Proliferation. Fu Y; Wen J; Li X; Gong M; Guo Z; Wang G Crit Rev Eukaryot Gene Expr; 2021; 31(5):27-32. PubMed ID: 34591387 [TBL] [Abstract][Full Text] [Related]
20. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells. Li H; Zhou Y; Cheng H; Tian J; Yang S Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]